Curcumin Scientific References and Clinical Study Library

Curcumin Scientific References: A Curated Clinical Study Library
Attention. Curcumin is among the most heavily marketed supplement ingredients, and its claims are rarely traced back to sources. This page gathers curcumin scientific references in one place so you can read the original papers instead of relying on a label or a headline.
Interest. Thousands of papers exist, but they are not equal. A test-tube result, a 40-person pilot trial and a pooled analysis of many trials carry very different weight. This library sorts studies by design, so you can see how strong each piece of evidence is.
1. How This Curcumin Study Library Is Organized
Entries run from strongest to weakest evidence type:
- Systematic reviews
- Meta-analyses
- Randomized controlled trials (RCTs)
- Observational human studies
- Pharmacokinetic studies
- Safety and toxicology studies
- Mechanistic studies
- Preclinical studies
Each entry gives authors, year, journal and DOI. I wrote these citations from memory, so open each DOI and confirm the details before you cite one. Where I could not confirm a detail, I left it out.
2. Systematic Reviews of Curcumin
- Gupta SC, Patchva S, Aggarwal BB. (2013). Therapeutic roles of curcumin: lessons learned from clinical trials. AAPS J 15(1):195–218. DOI: 10.1208/s12248-012-9432-8
- Hewlings SJ, Kalman DS. (2017). Curcumin: a review of its effects on human health. Foods 6(10):92. DOI: 10.3390/foods6100092
- Nelson KM, et al. (2017). The essential medicinal chemistry of curcumin. J Med Chem 60(5):1620–1637. DOI: 10.1021/acs.jmedchem.6b00975
The first two reviews describe promising human signals and call for larger trials. The third warns that curcumin’s chemical reactivity can produce misleading laboratory “hits.”
3. Meta-Analyses on Curcumin Clinical Studies
- Daily JW, Yang M, Park S. (2016). Efficacy of turmeric extracts and curcumin for alleviating the symptoms of joint arthritis: a systematic review and meta-analysis of randomized clinical trials. J Med Food 19(8):717–729. DOI: 10.1089/jmf.2016.3705
- Al-Karawi D, Al Mamoori DA, Tayyar Y. (2016). The role of curcumin administration in patients with major depressive disorder: mini meta-analysis of clinical trials. Phytother Res 30(2):175–183. DOI: 10.1002/ptr.5524
How to read them: joint-pain results are the most consistent, with modest effects. The depression meta-analysis pools very few small trials, so it is early evidence.
4. Randomized Controlled Trials of Curcumin
- Kuptniratsaikul V, et al. (2014). Efficacy and safety of Curcuma domestica extracts compared with ibuprofen in patients with knee osteoarthritis. Clin Interv Aging 9:451–458. DOI: 10.2147/CIA.S58535
- Sanmukhani J, et al. (2014). Efficacy and safety of curcumin in major depressive disorder: a randomized controlled trial. Phytother Res 28(4):579–585. DOI: 10.1002/ptr.5025
- Lopresti AL, et al. (2014). Curcumin for the treatment of major depression: a randomised, double-blind, placebo controlled study. J Affect Disord 167:368–375. DOI: 10.1016/j.jad.2014.06.001
- Cox KH, Pipingas A, Scholey AB. (2015). Investigation of the effects of solid lipid curcumin on cognition and mood in a healthy older population. J Psychopharmacol 29(5):642–651. DOI: 10.1177/0269881114552744
- Small GW, et al. (2018). Memory and brain amyloid and tau effects of a bioavailable form of curcumin in non-demented adults. Am J Geriatr Psychiatry 26(3):266–277. DOI: 10.1016/j.jagp.2017.10.010
5. Observational Human Studies
- Ng TP, Chiam PC, Lee T, et al. (2006). Curry consumption and cognitive function in the elderly. Am J Epidemiol 164(9):898–906. DOI: 10.1093/aje/kwj267
This population study found better cognitive test scores among people who ate curry more often. Observational designs cannot prove cause and effect, and curry intake does not equal a curcumin supplement dose.
6. Pharmacokinetic Studies of Curcumin Bioavailability
- Shoba G, et al. (1998). Influence of piperine on the pharmacokinetics of curcumin in animals and human volunteers. Planta Med 64(4):353–356. DOI: 10.1055/s-2006-957450
- Jäger R, et al. (2014). Comparative absorption of curcumin formulations. Nutr J 13:11. DOI: 10.1186/1475-2891-13-11
- Anand P, et al. (2007). Bioavailability of curcumin: problems and promises. Mol Pharm 4(6):807–818. DOI: 10.1021/mp700113r
- Sasaki H, et al. (2011). Innovative preparation of curcumin for improved oral bioavailability. Biol Pharm Bull 34(5):660–665. DOI: 10.1248/bpb.34.660
Together these show that plain curcumin is poorly absorbed and that piperine or special formulations raise blood levels. Most pharmacokinetic studies are small and often industry-supported.
7. Curcumin Safety Data and Toxicology Studies
- Lao CD, et al. (2006). Dose escalation of a curcuminoid formulation. BMC Complement Altern Med 6:10. DOI: 10.1186/1472-6882-6-10
- EFSA ANS Panel. (2010). Scientific opinion on the re-evaluation of curcumin (E 100) as a food additive. EFSA J 8(9):1679. DOI: 10.2903/j.efsa.2010.1679
- Forsyth JE, et al. (2019). Turmeric means “yellow” in Bengali: lead chromate pigments added to turmeric threaten public health across Bangladesh. Environ Res 179:108722. DOI: 10.1016/j.envres.2019.108722
What this means: doses up to 8 g per day were tolerated for a short time in a small group. EFSA set an acceptable daily intake of 3 mg per kg body weight as a food additive. Rare liver injury has been reported with some supplements, so people with liver conditions or on interacting medicines should consult a clinician. The Forsyth paper is about contamination risk, not curcumin itself, and shows why product testing matters.
8. Mechanistic Studies
- Aggarwal BB, Harikumar KB. (2009). Potential therapeutic effects of curcumin, the anti-inflammatory agent, against neurodegenerative, cardiovascular, pulmonary, metabolic, autoimmune and neoplastic diseases. Int J Biochem Cell Biol 41(1):40–59. DOI: 10.1016/j.biocel.2008.06.010
- Gupta et al. (2013) and Nelson et al. (2017) (listed above) also cover mechanisms.
Proposed pathways include NF-κB inhibition and Nrf2 activation. These are hypotheses based largely on cell work at concentrations higher than those reached in blood.
9. Preclinical Studies
- Yang F, et al. (2005). Curcumin inhibits formation of amyloid beta oligomers and fibrils, binds plaques, and reduces amyloid in vivo. J Biol Chem 280(7):5892–5901. DOI: 10.1074/jbc.M404751200
Animal and cell studies report anti-inflammatory, antioxidant and neuroprotective effects. These results justify human trials but do not prove benefit in people.
10. Study Table: Year, Design, Population and Dose
| Year | Study | Design | Population | Dose (as reported) |
|---|---|---|---|---|
| 1998 | Shoba et al. | Human PK study | Healthy volunteers | 2 g curcumin ± 20 mg piperine |
| 2006 | Lao et al. | Dose escalation | Healthy volunteers | Single doses up to 12 g |
| 2006 | Ng et al. | Observational | Older adults, Singapore | Curry intake frequency |
| 2014 | Kuptniratsaikul et al. | RCT vs ibuprofen | Knee osteoarthritis | About 1,500 mg extract per day |
| 2014 | Sanmukhani et al. | RCT | Major depressive disorder | About 1 g per day |
| 2014 | Lopresti et al. | RCT | Major depression | Reported in paper |
| 2015 | Cox et al. | RCT | Healthy older adults | Single daily solid-lipid dose |
| 2016 | Daily et al. | Meta-analysis | Joint arthritis trials | Varies |
| 2018 | Small et al. | RCT, 18 months | Non-demented adults | Bioavailable form, twice daily |
Doses and formulations differ across trials, so check each paper’s methods before comparing results.
Desire. A transparent bibliography lets you judge curcumin by its evidence. Joint pain has reasonable support, while mood, memory and other uses remain early.
Action. Bookmark this page, open the DOI links for the studies that matter to you, and speak with a qualified healthcare professional before using a supplement.
Disclaimer: this page is educational and does not replace professional medical advice.
For general information only. Talk to your doctor before starting any supplement.


